Drug profile · INN
ribavirin
RIBAVIRIN BIOPARTNERS
- US status
- approved
- Patents linked
- 2
- News articles
- 0
Quick answer
ribavirin (RIBAVIRIN BIOPARTNERS) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 8664273
Treatment of hepatitis C virus with telaprevir (VX-950) in patients non-responsive to treatment with pegylated interferon-alpha 2A/2B and ribavirin
granted -
US 7410979
Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections
granted
Frequently asked questions
What is ribavirin?
ribavirin (RIBAVIRIN BIOPARTNERS) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ribavirin?
RIBAVIRIN BIOPARTNERS is a marketed brand name for ribavirin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ribavirin?
ribavirin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.